Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2019 October;110(5) > Minerva Medica 2019 October;110(5):419-24



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Medica 2019 October;110(5):419-24

DOI: 10.23736/S0026-4806.19.06063-4


language: English

The influence of probiotic diet and chondroitin sulfate administration on Ptgs2, Tgfb1 and Col2a1 expression in rat knee cartilage during monoiodoacetate-induced osteoarthritis

Oleksandr H. KOROTKYI 1, Andrii A. VOVK 1, Alevtina S. DRANITSINA 1, Tetyana M. FALALYEYEVA 1 , Kateryna O. DVORSHCHENKO 1, Sharmila FAGOONEE 2, Liudmyla I. OSTAPCHENKO 1

1 Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 2 Institute of Biostructure and Bioimaging (CNR), Molecular Biotechnology Center, Turin, Italy

BACKGROUND: Osteoarthritis (OA) is a common worldwide disease induced by a wide range of biochemical processes, mainly inflammation and degradation of collagen. The aim of this study, was to describe the effect of a multistrain probiotic (PB) and chondroitin sulfate (CS), administered separately or in combination, on the expression of Ptgs2, Tgfb1 and Col2a1 during monoiodoacetate-induced OA in male rats.
METHODS: OA was induced in male rats by injecting monoiodoacetate in right hind knee. Therapeutic groups received 3 mg/kg of CS for 28 days and/or 1.4 g/kg of multistrain PB for 14 days. Knee cartilage were taken 30 days after monoiodoacetate injection. RNA was extracted and the expression of Ptgs2, Tgfb1 and Col2a1 were analyzed using SYBR Green 1-step real-time quantitative polymerase chain reaction.
RESULTS: Induction of OA caused an upregulation in Ptgs2, Tgfb1 expression, and downregulation of Col2a1. Separate administration of PB and CS reduced Ptgs2 and Tgfb1 expressions. Their combined administration significantly decreased the expression of these pro-inflammatory cytokines, comparable to controls. Expression of Col2a1 showed similar behavior, with upregulation in therapeutic group with separate administration and the cumulative effects in case of co-administration.
CONCLUSIONS: The multistrain PB diet may offer a perspective to improve the standard treatment of OA and, necessitates further investigation with clinical trials.

KEY WORDS: Osteoarthritis; Probiotics; Chondroitin sulfates; Gastrointestinal microbiome

top of page